Search results
Is BioNTech (BNTX) a Great Value Stock Right Now?
Zacks via Yahoo Finance· 2 years agoHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks....
BioNTech SE (NASDAQ:BNTX) stock most popular amongst private equity firms who own 44%, while...
Simply Wall St. via Yahoo Finance· 1 year agoA look at the shareholders of BioNTech SE (NASDAQ:BNTX) can tell us which group is most powerful....
Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That The Market Could be Wrong Given Its...
Simply Wall St. via Yahoo Finance· 1 year agoWith its stock down 19% over the past month, it is easy to disregard BioNTech (NASDAQ:BNTX). But if...
BioNTech SE's (NASDAQ:BNTX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market...
Simply Wall St. via Yahoo Finance· 7 months agoWith its stock down 12% over the past month, it is easy to disregard BioNTech (NASDAQ:BNTX)....
BioNTech SE Sponsored ADR (BNTX) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 1 year agoBioNTech SE Sponsored ADR (BNTX) closed at $124.57 in the latest trading session, marking a +1.63%...
BioNTech (BNTX) Inks Research Deal With Ryvu Therapeutics
Zacks via Yahoo Finance· 1 year agoBioNTech (BNTX) signs a research collaboration agreement with Ryvu Therapeutics to develop small...
BioNTech Trounces First-Quarter Profit Views, But Covid Declines Will Continue
Investor's Business Daily· 12 months agoBioNTech crushed Wall Street's profit expectations on Monday, but BNTX stock dipped at the close...
BioNTech Shares Up On Hope For Combined Flu, Covid Shot
Investor's Business Daily· 1 year agoPfizer and BioNTech started testing a combined flu and Covid vaccine on Thursday, helping BNTX stock...
Will Weakness in BioNTech SE's (NASDAQ:BNTX) Stock Prove Temporary Given Strong Fundamentals?
Simply Wall St. via Yahoo Finance· 2 months agoWith its stock down 7.5% over the past three months, it is easy to disregard BioNTech (NASDAQ:BNTX)....
BioNTech Pares Losses After Doubling Profits, Raising 2022 Guidance
Investor's Business Daily· 1 year agoBioNTech doubled Wall Street's third-quarter profit expectations Monday and raised its full-year...